GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/phase 2 trial

Journal:

Nature Medicine

Published:

2025-08-21

DOI:

10.1038/s41591-025-03874-6

Affiliations:

9

Authors:

28

Go to article

Institutions	Authors	Share
IRCCS Bambino Gesù Children's Hospital, Italy	25.500000 25.500000 25.500000	0.91
IRCCS National Cancer Institute (INT) Milan, Italy	1.000000	0.04
Catholic University of the Sacred Heart (UCSC), Italy	0.500000	0.02
University of Magna Graecia (UMG), Italy	0.500000	0.02
University of Naples Federico II (UNINA), Italy	0.500000	0.02

Interested in Oncology and Carcinogenesis?